Sign in
4

Changes in Ownership

Anebulo Pharmaceuticals, Inc. Filed Acc 0001493152-24-024125

Options or other derivatives

  • Director acquired 44,149 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lin Kenneth Director 2024-06-13 Grant or award · Stock Option (right to buy) +41,667 41,667 D: show line 1 in the form
Lin Kenneth Director 2024-06-13 Grant or award · Stock Option (right to buy) +2,482 2,482 D: show line 2 in the form
Loading xslF345X05/ownership.xml…